Stem Cell Network

Last chance to participate! 📢    SCN’s Training Needs Assessment Survey closes next week! Share your insights to shape future training initiatives, events, and opportunities! Enter to win one of five $50 Amazon gift cards! Survey closes on December 4. 👉 https://lnkd.in/eJDkqWje - Dernière chance de participer! 📢    Le Sondage du RCS sur les besoins de formation se termine la semaine prochaine! Participez pour aider à orienter nos initiatives, possibilités et événements de formation! Inscrivez-vous pour avoir la chance de gagner l’une de nos cinq cartes cadeau Amazon de 50 $! Le sondage se termine le 4 déc. 👉 https://lnkd.in/esXS-qBc

Dr. Amie Phinney, PhD, MBA, SCN's Vice President of Commercialization and Industry Engagement, participated in Life Sciences Ontario’s annual Queen’s Park Advocacy Day!    This event brings together companies and policymakers to showcase the tremendous potential of Ontario’s life sciences sector and to collaborate on solutions that can accelerate its growth. 🌱    Thanks to MPPs Natalie Pierre, Kristyn Wong-Tam, and Sheref Sabawy for chatting with us about the innovative #StemCell and #RegenMed research happening across Canada! 🇨🇦    And thank you to Life Sciences Ontario for organizing this important opportunity to strengthen the impact of #LifeSciences on our communities.

Missed our latest Careers Beyond Academia session? The recording is available on our YouTube channel! Watch Dr. Kevin Robb from STEMCELL Technologies and Dr. Danielle Spice from Stealth Mode Biotech discuss navigating big companies vs. startups, securing a place in the life sciences, and more! ⬇️ Medicine by Design - University of Toronto

📢 Deadline is around the corner!   SCN and BioCanRx are pleased to host "Best Practices for Collecting, Documenting, and Managing Research Data and Records," a 4-part interactive virtual workshop series with facilitators Rebecca L. Davies and Gayle Piat, providing foundational knowledge in research data and record management.    Learn more and register. ➡️ https://lnkd.in/eBacnTkF

📢 Attention all post-doctoral trainees! Contribute to advancements in Type 1 Diabetes research at the Breakthrough T1D Canada | Percée DT1 Centre of Excellence with the J. Andrew McKee Fellowship in Type 1 Diabetes at The University of British Columbia. Learn more and apply here. ➡️ https://lnkd.in/ejBr2Ytp

Last chance to register for the #MbDSymposium taking place on Dec. 9th. Registration closes this Friday. Save your spot today! Learn more and register here: https://lnkd.in/gGZwizpG

📢 Last chance to apply!   SCN, the University of Toronto's Applied Organoid Core, and the Network Biology Collaborative Centre at Mount Sinai are partnering up for the 2024 Organoid Symposium! 🔬   📅 Symposium: December 2 & 3 (Hybrid) ⏰ Apply by November 27 to attend virtually!   Get ready for groundbreaking insights, and networking with national and international experts in iPSC-derived #OrganoidResearch! Learn more and register for the Symposium today. ➡️ https://lnkd.in/eTJh5AkG   Thank you to our sponsors, Bio-Techne, Cedarlane Labs, Krembil Foundation, McEwen Stem Cell Institute, MilliporeSigma, Miltenyi Biotec, Nikon Canada Inc., Norgen Biotek, PeptiGrowth Inc., Sino Biological, Inc., STEMCELL Technologies, and Thermo Fisher Scientific, for supporting the 2024 Organoid Symposium & Workshop!   #OrganoidSymposium2024 #StemCellNetwork #UofT #ApOC #ResearchOpportunity

A decade ago, SCN’s Scientific Director, Dr. Michael Rudnicki, made a groundbreaking discovery linking #StemCells to #DuchenneMuscularDystrophy. Today, that breakthrough is paving the way for a potential treatment now in #ClinicalTrials, bringing new hope to transform the lives of those affected.

C’est parti! Nous sommes ravis de lancer Accélérer 2025-2029! Notre plan stratégique conçu pour « accélérer » la recherche sur les #CellulesSouches et la #MédecineRégénératrice tout en cultivant une communauté dynamique, nourrie par le talent, l’excellence et une passion commune pour une science transformatrice. 🔬     Guidé par notre nouvelle vision « Des vies transformées par la médecine régénératrice », le RCS : 💰 Financera la recherche depuis le stade du développement jusqu’aux essais cliniques initiaux  🎓 Formera la prochaine génération de talents pour qu’ils puissent occuper les emplois de demain   📢Renforcera les efforts de mobilisation des connaissances afin de favoriser l’adoption sur le terrain des résultats de la recherche   🛠️Bâtira un solide programme de préparation à la commercialisation qui permettra de faire cheminer les découvertes sur les cellules souches et la MR du laboratoire jusqu’aux patients, puis au marché.  Un grand merci à tous ceux et celles qui, au sein de notre communauté, ont contribué à la préparation d’Accélérer 2025-2029, y compris les chercheurs et les stagiaires du réseau, le conseil d’administration du RCS, les établissements membres et les partenaires. En d’autres termes, ce sont des personnes qui sont au cœur de la nouvelle vision du RCS, et nous ne pourrions pas faire ce que nous faisons sans vous. Enfin, nous tenons à saluer tout particulièrement Shift Health pour son soutien à l’élaboration d’Accelerate 2025-2029, ainsi que spark*advocacy pour avoir donné vie à ces pages! Declan Hamill Michael Rudnicki Nadine Beauger Gail Garland Michael Kallos Ekat Kritikou Sharon Louis Gordon McCauley (He/Him) Tamer Mohamed Reza Moridi Rajat Sharma, CPA Molly Shoichet Téléchargez le plan stratégique ici. https://lnkd.in/efFXgidd 

Today’s the day! We’re excited to launch Accelerate 2025-2029! Our strategic plan is designed to ‘accelerate’ #StemCell and #RegenerativeMedicine research while cultivating a vibrant community, driven by talent, excellence, and a shared passion for transformative science. 🔬     Guided by our new vision “Lives transformed by regenerative medicine,” SCN will:  💰 Fund research from development through to early-stage clinical trials  🎓 Train the next generation of talent to take on the jobs of the future   📢 Enhance knowledge mobilization efforts to ensure the uptake of research produced in the field   🛠️ Build a robust commercialization readiness program that will allow for the translation of stem cell and RM discoveries from the lab to patients, to the marketplace     A very big thank you to those in the community who contributed to building Accelerate 2025-2029 including Network researchers and trainees, SCN’s Board of Directors, member institutions, and partners. Simply put, people are at the heart of SCN’s new and refreshed vision, and we could not do what we do without you.      Finally, a very special shout out to Shift Health for your work in supporting the development of Accelerate 2025-2029, and to spark*advocacy for making the pages come to life! Declan Hamill Michael Rudnicki Nadine Beauger Gail Garland Michael Kallos Ekat Kritikou Sharon Louis Gordon McCauley (He/Him) Tamer Mohamed Reza Moridi Rajat Sharma, CPA Molly Shoichet   Download the strategic plan here.  https://lnkd.in/eKucvhes